Cargando…
The Abnormal CD4+T Lymphocyte Subset Distribution and Vbeta Repertoire in New-onset Rheumatoid Arthritis Can Be Modulated by Methotrexate Treament
Patients with long-term, treated, rheumatoid arthritis (RA) show abnormalities in their circulating CD4+ T-lymphocytes, but whether this occurs in recently diagnosed naïve patients to disease-modifying drugs (DMARDs) is under discussion. These patients show heterogeneous clinical response to methotr...
Autores principales: | Monserrat, Jorge, Bohórquez, Cristina, Gómez Lahoz, Ana María, Movasat, Atusa, Pérez, Ana, Ruíz, Lucía, Díaz, David, Chara, Luis, Sánchez, Ana Isabel, Albarrán, Fernando, Sanz, Ignacio, Álvarez-Mon, Melchor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721760/ https://www.ncbi.nlm.nih.gov/pubmed/31405169 http://dx.doi.org/10.3390/cells8080871 |
Ejemplares similares
-
Methrotexate Treatment Inmunomodulates Abnormal Cytokine Expression by T CD4 Lymphocytes Present in DMARD-Naïve Rheumatoid Arthritis Patients
por: Monserrat Sanz, Jorge, et al.
Publicado: (2020) -
The number of circulating monocytes as biomarkers of the clinical response to methotrexate in untreated patients with rheumatoid arthritis
por: Chara, Luis, et al.
Publicado: (2015) -
Principles of heat treament
por: Grossmann, M A
Publicado: (1935) -
Stimulants in the Treament of Disease
Publicado: (1870) -
Monocyte populations as markers of response to adalimumab plus MTX in rheumatoid arthritis
por: Chara, Luis, et al.
Publicado: (2012)